<div>
  <p>
  </p>
  <ul>
    <li>
      <p>
        California-based AI preclinical experiment company VeriSIM Life and UK-based analytics company Clarivate have extended their existing partnership (initially entered in 
        <a href="https://sp-edge.com/updates/18034">
          April 2023
        </a>
        ) to launch VeriSIM Life Translational Index on Clarivate's Cortellis Drug Discovery Intelligence platform. The terms and financial details of the agreement have not been disclosed.
      </p>
    </li>
    <li>
      <p>
        The new tool offers predictive insights into factors related to the development of drugs, such as bioavailability, clearance rates, toxicity, and first-in-human dose when combined with Clarivate's Cortellis Drug Discovery Intelligence.
      </p>
    </li>
    <li>
      <p>
        The partnership aims to accelerate drug development, improve preclinical success rates, and help biotech and pharmaceutical companies manage risks more effectively using AI-enabled workflows.
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://clarivate.com/news/clarivate-expands-partnership-with-verisim-life-to-accelerate-and-de-risk-research-and-drug-development/">
      Press release
    </a>
  </p>
  <p>
  </p>
</div>


AI Drug Discovery

PROMINENT_CATEGORY

<div>
<p>California-based AI preclinical experiment company VeriSIM Life and UK-based analytics company Clarivate have extended their existing partnership (initially entered in <a href="https://sp-edge.com/updates/18034"> April 2023 </a> ) to launch VeriSIM Life Translational Index on Clarivate's Cortellis Drug Discovery Intelligence platform. The terms and financial details of the agreement have not been disclosed.</p>
<p>The new tool offers predictive insights into factors related to the development of drugs, such as bioavailability, clearance rates, toxicity, and first-in-human dose when combined with Clarivate's Cortellis Drug Discovery Intelligence.</p>
<p>The partnership aims to accelerate drug development, improve preclinical success rates, and help biotech and pharmaceutical companies manage risks more effectively using AI-enabled workflows.</p>
</div> California-based AI preclinical experiment company VeriSIM Life and UK-based analytics company Clarivate have extended their partnership to launch VeriSIM Life Translational Index on Clarivate's Cortellis Drug Discovery Intelligence platform. The tool provides predictive insights into drug development factors and aims to accelerate drug development, improve preclinical success rates, and help manage risks using AI-enabled workflows.

VeriSIM Life extends collaboration with Clarivate to develop AI-enabled workflow

All Updates

VeriSIM Life extends collaboration with Clarivate to develop AI-enabled workflow

VeriSIM Life partners with Clarivate to accelerate drug development

VeriSIM Life and Mayo Clinic team up to accelerate AI drug discovery

VeriSIM Life and Total Brain partner to develop novel drugs for neurological disorders

VeriSIM Life acquires Molomics Biotech for enhanced AI drug discovery

VeriSIM Life raises USD 15 million in oversubscribed Series A